EconPapers    
Economics at your fingertips  
 

Synthetic molecular recognition nanosensor paint for microalbuminuria

Januka Budhathoki-Uprety, Janki Shah, Joshua A. Korsen, Alysandria E. Wayne, Thomas V. Galassi, Joseph R. Cohen, Jackson D. Harvey, Prakrit V. Jena, Lakshmi V. Ramanathan, Edgar A. Jaimes and Daniel A. Heller ()
Additional contact information
Januka Budhathoki-Uprety: Memorial Sloan Kettering Cancer Center
Janki Shah: Memorial Sloan Kettering Cancer Center
Joshua A. Korsen: Memorial Sloan Kettering Cancer Center
Alysandria E. Wayne: Memorial Sloan Kettering Cancer Center
Thomas V. Galassi: Memorial Sloan Kettering Cancer Center
Joseph R. Cohen: Memorial Sloan Kettering Cancer Center
Jackson D. Harvey: Memorial Sloan Kettering Cancer Center
Prakrit V. Jena: Memorial Sloan Kettering Cancer Center
Lakshmi V. Ramanathan: Memorial Sloan Kettering Cancer Center
Edgar A. Jaimes: Memorial Sloan Kettering Cancer Center
Daniel A. Heller: Memorial Sloan Kettering Cancer Center

Nature Communications, 2019, vol. 10, issue 1, 1-9

Abstract: Abstract Microalbuminuria is an important clinical marker of several cardiovascular, metabolic, and other diseases such as diabetes, hypertension, atherosclerosis, and cancer. The accurate detection of microalbuminuria relies on albumin quantification in the urine, usually via an immunoturbidity assay; however, like many antibody-based assessments, this method may not be robust enough to function in global health applications, point-of-care assays, or wearable devices. Here, we develop an antibody-free approach using synthetic molecular recognition by constructing a polymer to mimic fatty acid binding to the albumin, informed by the albumin crystal structure. A single-walled carbon nanotube, encapsulated by the polymer, as the transduction element produces a hypsochromic (blue) shift in photoluminescence upon the binding of albumin in clinical urine samples. This complex, incorporated into an acrylic material, results in a nanosensor paint that enables the detection of microalbuminuria in patient samples and comprises a rapid point-of-care sensor robust enough to be deployed in resource-limited settings.

Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-019-11583-1 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-11583-1

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-019-11583-1

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-11583-1